Todd Wider - Jul 31, 2024 Form 4 Insider Report for ARYA Sciences Acquisition Corp IV (ARYD)

Role
Director
Signature
/s/ Samuel M. Cohn, attorney-in-fact
Stock symbol
ARYD
Transactions as of
Jul 31, 2024
Transactions value $
$0
Form type
4
Date filed
7/31/2024, 09:43 PM
Previous filing
Oct 30, 2023
Next filing
Aug 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARYD Class B ordinary shares Disposed to Issuer -30K -100% 0 Jul 31, 2024 Class A ordinary shares 30K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Todd Wider is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) ("HoldCo"), Aja Merger Sub 1 ("Merger Sub 1"), Aja Merger Sub 2, Inc. ("Merger Sub 2") and Adagio Medical, Inc. ("Adagio") (the transactions contemplated thereby, the "Business Combination"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis.